LIPOPROTEIN(A) AND WOMEN'S CARDIOVASCULAR HEALTH

Erin D. Michos, MD, MHS, Stephanie Saucier, MD, Roxana Mehran, MD, Marlys L. Koschinsky, PhD

Elevated lipoprotein(a), or Lp(a), is a genetically determined risk factor for cardiovascular disease (CVD), particularly in women. The review emphasizes the importance of understanding how Lp(a) levels fluctuate due to hormonal changes, especially during pregnancy and postmenopause. It advocates for increased awareness among healthcare professionals regarding the risks associated with elevated Lp(a) levels and the necessity for further research in this area. The authors call for actionable strategies to mitigate CVD risk in women, despite the absence of approved pharmacological therapies for lowering Lp(a).